Literature DB >> 21203754

Current research in nuclear medicine and molecular imaging: highlights of the 23rd Annual EANM Congress.

Ignasi Carrió1.   

Abstract

The most recent research developments in nuclear medicine and molecular imaging were presented at the 2010 Annual Congress of the EANM. This review summarizes some of the most relevant contributions made in the fields of oncology, cardiovascular science, neurology and psychiatry, technological innovation and novel tracers. Presentations covered basic and clinical research in nuclear medicine and molecular imaging, and diagnostic and therapeutic applications of radioisotopes and radiopharmaceuticals on a global scale. The results reported demonstrate that investigative strategies using nuclear medicine techniques facilitate effective diagnosis and management of patients with most prevalent disease states. At the same time novel tracers and technologies are being explored, which hold promise for future new applications of nuclear medicine and molecular imaging in research and clinical practice.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21203754     DOI： 10.1007/s00259-010-1698-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


  3 in total

1.  Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.

Authors:  Luigi Aloj; Michela Aurilio; Valentina Rinaldi; Laura D'ambrosio; Diego Tesauro; Petra Kolenc Peitl; Theodosia Maina; Rosalba Mansi; Elisabeth von Guggenberg; Lieke Joosten; Jane K Sosabowski; Wouter A P Breeman; Erik De Blois; Stuart Koelewijn; Marleen Melis; Beatrice Waser; Karin Beetschen; Jean Claude Reubi; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-20       Impact factor: 9.236

2.  Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.

Authors:  Helle-Brit Fiebrich; Johan R de Jong; Ido P Kema; Klaas Pieter Koopmans; Wim Sluiter; Rudi A J O Dierckx; Annemiek M Walenkamp; Thera P Links; Adrienne H Brouwers; Elisabeth G E de Vries
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

3.  Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.

Authors:  Rogier P J Schroeder; W M van Weerden; E P Krenning; C H Bangma; S Berndsen; C H Grievink-de Ligt; H C Groen; S Reneman; E de Blois; W A P Breeman; M de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-23       Impact factor: 9.236
  3 in total
  2 in total

1.  Disrupted-in-schizophrenia1 (DISC1) L100P mutation alters synaptic transmission and plasticity in the hippocampus and causes recognition memory deficits.

Authors:  Lin Cui; Wei Sun; Ming Yu; Nan Li; Li Guo; Huating Gu; Yu Zhou
Journal:  Mol Brain       Date:  2016-10-12       Impact factor: 4.041

2.  The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms.

Authors:  Yongkun Yang; Tobias Neef; Christian Mittelholzer; Elisa Garcia Garayoa; Peter Bläuenstein; Roger Schibli; Ueli Aebi; Peter Burkhard
Journal:  J Nanobiotechnology       Date:  2013-11-12       Impact factor: 10.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.